PIPOTIAZINE PALMITATE

UNII: 4Q3H01QRMI
Formula: C40H63N3O4S2
Preferred Substance Name: PIPOTIAZINE PALMITATE
InChIKey: KTOYYUONFQWSMW-UHFFFAOYSA-N

37517-26-3
253-536-4
10-(3-(4-(2-HYDROXYETHYL)PIPERIDINO)PROPYL)-N,N-DIMETHYLPHENOTHIAZINE-2-SULFONAMIDE PALMITATE (ESTER)
19552 RP
HEXADECANOIC ACID, 2-(1-(3-(2-((DIMETHYLAMINO)SULFONYL)-10H-PHENOTHIAZIN-10-YL)PROPYL)-4-PIPERIDINYL)ETHYL ESTER
IL-19552
PIPORTIL DEPOT
PIPOTIAZINE PALMITATE [MART.]
PIPOTIAZINE PALMITATE [USAN]
PIPOTIAZINE PALMITATE [WHO-DD]
PIPOTIAZINE PALMITIC ESTER
PIPOTIAZINE PALMITIC ESTER [MI]
RP 19552
RP-19552

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

PIPOTIAZINE PALMITATE

Synonyms and Mappings

Resources

Note